Cargando...
Paricalcitol Inhibits Wnt/β-Catenin Signaling Pathway and Ameliorates Dermal Fibrosis in Bleomycin Induced Scleroderma Model
OBJECTIVES: This study aims to determine the prophylactic and therapeutic efficacy of inhibition of Wnt/β-catenin signaling pathway with paricalcitol in an experimental scleroderma model created with bleomycin (BLM). MATERIALS AND METHODS: Sixty female BALB/c mice (8-week old and weighing 25 g to 30...
Guardado en:
| Publicado en: | Arch Rheumatol |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Turkish League Against Rheumatism
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6328211/ https://ncbi.nlm.nih.gov/pubmed/30632522 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5606/ArchRheumatol.2018.6648 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|